img

Global Nucleic Acid Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Nucleic Acid Drugs Market Research Report 2024

Nucleic Acid Drugs are pharmaceutical compounds that target nucleic acids (DNA or RNA) for therapeutic purposes, including gene therapy and antisense therapy.
According to MRA Research’s new survey, global Nucleic Acid Drugs market is projected to reach US$ 267.6 million in 2033, increasing from US$ 76 million in 2023, with the CAGR of 18.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Segment by Type
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other

Segment by Application


Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nucleic Acid Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Antisense Nucleic Acid Drugs
1.2.3 siRNA Drugs
1.2.4 saRNA Drugs
1.2.5 miRNA Drugs
1.2.6 mRNA Drugs
1.2.7 other
1.3 Market by Application
1.3.1 Global Nucleic Acid Drugs Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Drugs Market Perspective (2018-2033)
2.2 Nucleic Acid Drugs Growth Trends by Region
2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Nucleic Acid Drugs Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Drugs Forecasted Market Size by Region (2024-2033)
2.3 Nucleic Acid Drugs Market Dynamics
2.3.1 Nucleic Acid Drugs Industry Trends
2.3.2 Nucleic Acid Drugs Market Drivers
2.3.3 Nucleic Acid Drugs Market Challenges
2.3.4 Nucleic Acid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Drugs Players by Revenue
3.1.1 Global Top Nucleic Acid Drugs Players by Revenue (2018-2023)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Drugs Revenue
3.4 Global Nucleic Acid Drugs Market Concentration Ratio
3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Drugs Revenue in 2023
3.5 Nucleic Acid Drugs Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Drugs Product Solution and Service
3.7 Date of Enter into Nucleic Acid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Drugs Breakdown Data by Type
4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2033)
5 Nucleic Acid Drugs Breakdown Data by Application
5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nucleic Acid Drugs Market Size (2018-2033)
6.2 North America Nucleic Acid Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Nucleic Acid Drugs Market Size by Country (2018-2023)
6.4 North America Nucleic Acid Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Drugs Market Size (2018-2033)
7.2 Europe Nucleic Acid Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Nucleic Acid Drugs Market Size by Country (2018-2023)
7.4 Europe Nucleic Acid Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Drugs Market Size (2018-2033)
8.2 Asia-Pacific Nucleic Acid Drugs Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Nucleic Acid Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Nucleic Acid Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Drugs Market Size (2018-2033)
9.2 Latin America Nucleic Acid Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Nucleic Acid Drugs Market Size by Country (2018-2023)
9.4 Latin America Nucleic Acid Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Drugs Market Size (2018-2033)
10.2 Middle East & Africa Nucleic Acid Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Nucleic Acid Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Nucleic Acid Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Detail
11.1.2 Sarepta Therapeutics Business Overview
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction
11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.1.5 Sarepta Therapeutics Recent Development
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Detail
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction
11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Alnylam
11.3.1 Alnylam Company Detail
11.3.2 Alnylam Business Overview
11.3.3 Alnylam Nucleic Acid Drugs Introduction
11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023)
11.3.5 Alnylam Recent Development
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics Company Detail
11.4.2 Mina Therapeutics Business Overview
11.4.3 Mina Therapeutics Nucleic Acid Drugs Introduction
11.4.4 Mina Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.4.5 Mina Therapeutics Recent Development
11.5 BioNTech
11.5.1 BioNTech Company Detail
11.5.2 BioNTech Business Overview
11.5.3 BioNTech Nucleic Acid Drugs Introduction
11.5.4 BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023)
11.5.5 BioNTech Recent Development
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals Company Detail
11.6.2 NeXstar Pharmaceuticals Business Overview
11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Introduction
11.6.4 NeXstar Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
11.6.5 NeXstar Pharmaceuticals Recent Development
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Detail
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Nucleic Acid Drugs Introduction
11.7.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023)
11.7.5 Nippon Shinyaku Recent Development
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics Company Detail
11.8.2 Moderna Therapeutics Business Overview
11.8.3 Moderna Therapeutics Nucleic Acid Drugs Introduction
11.8.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.8.5 Moderna Therapeutics Recent Development
11.9 CureVac
11.9.1 CureVac Company Detail
11.9.2 CureVac Business Overview
11.9.3 CureVac Nucleic Acid Drugs Introduction
11.9.4 CureVac Revenue in Nucleic Acid Drugs Business (2018-2023)
11.9.5 CureVac Recent Development
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics Company Detail
11.10.2 Regulus Therapeutics Business Overview
11.10.3 Regulus Therapeutics Nucleic Acid Drugs Introduction
11.10.4 Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.10.5 Regulus Therapeutics Recent Development
11.11 Miragen Therapeutics
11.11.1 Miragen Therapeutics Company Detail
11.11.2 Miragen Therapeutics Business Overview
11.11.3 Miragen Therapeutics Nucleic Acid Drugs Introduction
11.11.4 Miragen Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
11.11.5 Miragen Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Antisense Nucleic Acid Drugs
Table 3. Key Players of siRNA Drugs
Table 4. Key Players of saRNA Drugs
Table 5. Key Players of miRNA Drugs
Table 6. Key Players of mRNA Drugs
Table 7. Key Players of other
Table 8. Global Nucleic Acid Drugs Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 9. Global Nucleic Acid Drugs Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 10. Global Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Nucleic Acid Drugs Market Share by Region (2018-2023)
Table 12. Global Nucleic Acid Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Nucleic Acid Drugs Market Share by Region (2024-2033)
Table 14. Nucleic Acid Drugs Market Trends
Table 15. Nucleic Acid Drugs Market Drivers
Table 16. Nucleic Acid Drugs Market Challenges
Table 17. Nucleic Acid Drugs Market Restraints
Table 18. Global Nucleic Acid Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Nucleic Acid Drugs Market Share by Players (2018-2023)
Table 20. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2023)
Table 21. Ranking of Global Top Nucleic Acid Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nucleic Acid Drugs Product Solution and Service
Table 25. Date of Enter into Nucleic Acid Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Nucleic Acid Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Nucleic Acid Drugs Revenue Market Share by Type (2024-2033)
Table 31. Global Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Nucleic Acid Drugs Revenue Market Share by Application (2018-2023)
Table 33. Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Nucleic Acid Drugs Revenue Market Share by Application (2024-2033)
Table 35. North America Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. North America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 39. Europe Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Nucleic Acid Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 42. Asia-Pacific Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Nucleic Acid Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Latin America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 48. Middle East & Africa Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nucleic Acid Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 50. Sarepta Therapeutics Company Detail
Table 51. Sarepta Therapeutics Business Overview
Table 52. Sarepta Therapeutics Nucleic Acid Drugs Product
Table 53. Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 54. Sarepta Therapeutics Recent Development
Table 55. Ionis Pharmaceuticals Company Detail
Table 56. Ionis Pharmaceuticals Business Overview
Table 57. Ionis Pharmaceuticals Nucleic Acid Drugs Product
Table 58. Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 59. Ionis Pharmaceuticals Recent Development
Table 60. Alnylam Company Detail
Table 61. Alnylam Business Overview
Table 62. Alnylam Nucleic Acid Drugs Product
Table 63. Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 64. Alnylam Recent Development
Table 65. Mina Therapeutics Company Detail
Table 66. Mina Therapeutics Business Overview
Table 67. Mina Therapeutics Nucleic Acid Drugs Product
Table 68. Mina Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 69. Mina Therapeutics Recent Development
Table 70. BioNTech Company Detail
Table 71. BioNTech Business Overview
Table 72. BioNTech Nucleic Acid Drugs Product
Table 73. BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 74. BioNTech Recent Development
Table 75. NeXstar Pharmaceuticals Company Detail
Table 76. NeXstar Pharmaceuticals Business Overview
Table 77. NeXstar Pharmaceuticals Nucleic Acid Drugs Product
Table 78. NeXstar Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 79. NeXstar Pharmaceuticals Recent Development
Table 80. Nippon Shinyaku Company Detail
Table 81. Nippon Shinyaku Business Overview
Table 82. Nippon Shinyaku Nucleic Acid Drugs Product
Table 83. Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 84. Nippon Shinyaku Recent Development
Table 85. Moderna Therapeutics Company Detail
Table 86. Moderna Therapeutics Business Overview
Table 87. Moderna Therapeutics Nucleic Acid Drugs Product
Table 88. Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 89. Moderna Therapeutics Recent Development
Table 90. CureVac Company Detail
Table 91. CureVac Business Overview
Table 92. CureVac Nucleic Acid Drugs Product
Table 93. CureVac Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 94. CureVac Recent Development
Table 95. Regulus Therapeutics Company Detail
Table 96. Regulus Therapeutics Business Overview
Table 97. Regulus Therapeutics Nucleic Acid Drugs Product
Table 98. Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 99. Regulus Therapeutics Recent Development
Table 100. Miragen Therapeutics Company Detail
Table 101. Miragen Therapeutics Business Overview
Table 102. Miragen Therapeutics Nucleic Acid Drugs Product
Table 103. Miragen Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 104. Miragen Therapeutics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Nucleic Acid Drugs Market Share by Type: 2023 VS 2033
Figure 3. Antisense Nucleic Acid Drugs Features
Figure 4. siRNA Drugs Features
Figure 5. saRNA Drugs Features
Figure 6. miRNA Drugs Features
Figure 7. mRNA Drugs Features
Figure 8. other Features
Figure 9. Global Nucleic Acid Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Nucleic Acid Drugs Market Share by Application: 2023 VS 2033
Figure 11. Genetic Disease Case Studies
Figure 12. Cancer Case Studies
Figure 13. Cardiovascular Diseases Case Studies
Figure 14. Other Case Studies
Figure 15. Nucleic Acid Drugs Report Years Considered
Figure 16. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Nucleic Acid Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 18. Global Nucleic Acid Drugs Market Share by Region: 2023 VS 2033
Figure 19. Global Nucleic Acid Drugs Market Share by Players in 2023
Figure 20. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid Drugs Revenue in 2023
Figure 22. North America Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 24. United States Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 28. Germany Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Nucleic Acid Drugs Market Share by Region (2018-2033)
Figure 36. China Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 44. Mexico Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Nucleic Acid Drugs Market Share by Country (2018-2033)
Figure 48. Turkey Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Nucleic Acid Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 51. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 52. Alnylam Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 53. Mina Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 54. BioNTech Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 55. NeXstar Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 56. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 57. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 58. CureVac Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 59. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 60. Miragen Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries